Intratumoral co-activation of ERV transcription and RNA virus-sensing is associated with radiotherapy-induced immune response and abscopal effect


Creative Commons License

Logotheti S., Yıldız E., Hasan S., Bulanova V., Theodoridou E., Kuhn S., ...Daha Fazla

npj Precision Oncology, cilt.10, sa.1, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 1
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1038/s41698-026-01715-4
  • Dergi Adı: npj Precision Oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals, Health Research Premium Collection (ProQuest)
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Radiotherapy (RT) transforms tumors into in situ vaccines that trigger antitumor immunity. However, the relevant pathways remain largely unelucidated, limiting clinical translation. Herein, we developed a hybrid dry-lab/wet-lab approach integrating systems-level immune phenotypes following homogenous or spatially fractionated RT (SFRT) with transcriptomic profiling of irradiated tumors. By combining feature extraction with machine-learning, including multilayer perceptron modeling, we ranked predictors of immune infiltration and patient survivability for each RT type. RT induced coordinated upregulation of viral RNA-binding proteins (OASes and RIG I-like receptors) along with endogenous retrovirus (ERV) RNAs predominately 400–800 bp long, which may serve as their ligands. During abscopal responses, OASes and ERV transcripts were co-induced and shared between irradiated and distant tumors. SFRT triggered earlier activation of OAS signaling versus homogenous RT. Our findings highlight ERVs as underappreciated contributors to RT-induced antitumor immunity and their interactions with intratumoral cytosolic sensors as potential novel biomarkers in precision radio-oncology.